Tumor necrosis factor receptor 1 associates with CD137 ligand and mediates its reverse signaling

Expression of CD137 on Hodgkin and Reed-Sternberg Cells Inhibits T-cell Activation by Eliminating CD137 Ligand Expression

(2012) W. T. Ho et al.   CANCER RESEARCH

Requirement of Transmembrane Domain for CD154 Association to Lipid Rafts and Subsequent Biological Events

(2012) Nadir Benslimane et al.   PLoS One

Recombinant TAT-CD137 Ligand Cytoplasmic Domain Fusion Protein Induces the Production of IL-6 and TNF-α in Peritoneal Macrophages

(2011) Jung Dae Kim et al.   Immune Network

CD137 ligand signaling induces human monocyte to dendritic cell differentiation

(2010) Shaqireen Kwajah M. M. et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction

(2010) Zhe Shao et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Inhibition of Proliferation and Induction of Apoptosis in Multiple Myeloma Cell Lines by CD137 Ligand Signaling

(2010) Charles Gullo et al.   PLoS One

A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling

(2009) Songwen Ju et al.   INTERNATIONAL IMMUNOLOGY

The Structure of the Trimer of Human 4-1BB Ligand Is Unique among Members of the Tumor Necrosis Factor Superfamily

(2009) Eun-Young Won et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab

(2008) Hiroki Mitoma et al.   ARTHRITIS AND RHEUMATISM